Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products by the FDA

ID: adjusting-for-covariates-in-randomized-clinical-trials-for-drugs-and-biological-products-by-the-fda

FDA guidance, May 2023. Sections I–II, printed pp. 1–2: prognostic pre-randomization covariates and precision. Institutional source; reuse live FDA entry if present. Numerical residual-variance example is an independent derivation under the stated conditional noise assumptions.

New to topics? Read the docs here!